Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Change in Account Payables (2017 - 2026)

Kodiak Sciences' (KOD) quarterly Change in Account Payables came in at -$733000.0 in Q1 2026, down 128.13% YoY from $2.6 million in Q1 2025, and down 145.08% on a QoQ basis from $1.6 million in Q4 2025.

Analysis

Kodiak Sciences (KOD) Change in Account Payables (2017 - 2026) Analysis & Trends

Kodiak Sciences (KOD) has 10 years of Change in Account Payables data on file, last reported at -$733000.0 in Q1 2026.

  • Quarterly Change in Account Payables fell 128.13% year-over-year to -$733000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (up 17.22% YoY) and the FY2025 annual result came in at $8.1 million, up 183.26% from the prior year.
  • Change in Account Payables fell to -$733000.0 in Q1 2026, from $1.6 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $6.5 million in Q1 2022 to a low of -$11.1 million in Q1 2024.
  • A 5-year average of $288294.1 and a median of $637000.0 in 2024 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2022 — Change in Account Payables soared 4042.42% — and 2024, when it slumped 485.42%.
  • Tracing KOD's Change in Account Payables over 5 years: stood at -$5.4 million in 2022, then jumped by 145.74% to $2.5 million in 2023, then plunged by 74.35% to $637000.0 in 2024, then surged by 155.26% to $1.6 million in 2025, then sank by 145.08% to -$733000.0 in 2026.
  • The last three Change in Account Payables figures came in at -$733000.0 (Q1 2026), $1.6 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Kodiak Sciences 2.21 Bn 2.21 Bn - 982,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 982,000.00
Mar 31, 2026 -733,000.00
Dec 31, 2025 1.63 Mn
Sep 30, 2025 5.32 Mn
Jun 30, 2025 -1.48 Mn
Mar 31, 2025 2.61 Mn
Dec 31, 2024 637,000.00
Sep 30, 2024 1.58 Mn
Jun 30, 2024 -791,000.00
Mar 31, 2024 -11.12 Mn
Dec 31, 2023 2.48 Mn
Sep 30, 2023 -435,000.00
Jun 30, 2023 5.45 Mn
Mar 31, 2023 -1.90 Mn
Dec 31, 2022 -5.43 Mn
Sep 30, 2022 -5.78 Mn
Jun 30, 2022 6.36 Mn
Mar 31, 2022 6.51 Mn
Dec 31, 2021 -5.35 Mn
Sep 30, 2021 9.01 Mn